Systems modeling: a pathway to drug discovery
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 9 (4) , 400-406
- https://doi.org/10.1016/j.cbpa.2005.06.008
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signalingJournal of Theoretical Biology, 2005
- Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in CancerJournal of Clinical Oncology, 2005
- Illuminating drug discovery with biological pathwaysFEBS Letters, 2005
- Integrating cell-level kinetic modeling into the design of engineered protein therapeuticsNature Biotechnology, 2005
- Structural genomics of GPCRsTrends in Biotechnology, 2005
- Intracoronary administration of FGF-2: a computational model of myocardial deposition and retentionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Systems biology in drug discoveryNature Biotechnology, 2004
- Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor EndocytosisPublished by Elsevier ,2003
- Computational modeling of the EGF-receptor system: a paradigm for systems biologyPublished by Elsevier ,2003
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2Circulation, 2002